<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-127</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКОЕ И КЛИНИЧЕСКОЕ ИЗУЧЕНИЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL AND CLINICAL STUDY OF MEDICINES</subject></subj-group></article-categories><title-group><article-title>Оценка фармакокинетики эндогенных соединений на примере препаратов кальция</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of endogenous compounds pharmacokinetics as illustrated by calcium</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еременко</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremenko</surname><given-names>N. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горячев</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Goryachev</surname><given-names>D. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ших</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shikh</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр экспертизы средств медицинского применения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Expert Evaluation of Medicinal Products</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2018</year></pub-date><volume>7</volume><issue>2</issue><fpage>104</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Еременко Н.Н., Горячев Д.В., Ших Е.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Еременко Н.Н., Горячев Д.В., Ших Е.В.</copyright-holder><copyright-holder xml:lang="en">Eremenko N.N., Goryachev D.V., Shikh E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/127">https://www.vedomostincesmp.ru/jour/article/view/127</self-uri><abstract><p>В статье представлен анализ данных научной литературы по вопросам проведения фармакокинетических исследований invivo лекарственных препаратов, аналогов эндогенных соединений. Рассмотрены подходы к оценке фармакокинетических параметров лекарственных препаратов кальция. Установлено, что для оценки фармакокинетических параметров лекарственных препаратов, содержащих в своем составе ионы кальция в виде различных солей, необходимо изучение нескольких фармакокинетических параметров: параметры, характеризующих абсорбцию кальция (Cmax и AUC с учетом фоновых эндогенных концентраций кальция), гомеостатические механизмы, регулирующие концентрацию данного эндогенного соединения (параметры выведения кальция), а также гормональную регуляцию фосфатно-кальциевого гомеостаза (паратиреоидный гормон).</p></abstract><trans-abstract xml:lang="en"><p>The article reviews scientific literature on the conduct of in vivo pharmacokinetic studies of drugs that are similar to endogenous compounds. It summarises approaches to pharmacokinetic evaluation of calcium drugs. It was demonstrated that the pharmacokinetic evaluation of drugs containing calcium ions in the form of various salts requires assessment of several parameters: parameters indicative of calcium absorption (Cmax and AUC with due regard to baseline concentrations of endogenous calcium), homeostatic mechanisms which regulate the concentration of this endogenous compound (calcium excretion parameters) and hormonal regulation of phosphate and calcium homeostasis (parathyroid hormone).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фармакокинетика</kwd><kwd>клинические исследования in vivo</kwd><kwd>паратгормон</kwd><kwd>кальций</kwd><kwd>эндогенные соединения</kwd><kwd>pharmacokinetics</kwd><kwd>clinical studies in vivo</kwd><kwd>parathormone</kwd><kwd>calcium</kwd><kwd>endogenous compounds</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Адонин ВК, Ромодановский ДП, Ниязов РР. Особенности проведения исследования биоэквивалентности лекарственных препаратов - аналогов эндогенных соединений. Ведомости Научного центра экспертизы средств медицинского применения 2015; (3): 3-8.</mixed-citation><mixed-citation xml:lang="en">Adonin VK, Romodanovskiy DP, Niyazov RR. Specific features of  the bioequivalence  study of drugs—analogs of endogenous compounds. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2015; (3): 3–8 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Государственный реестр лекарственных средств. Available from: http://grls.rosminzdrav.ru/.</mixed-citation><mixed-citation xml:lang="en">State Register of medicines. Available from: http://grls.rosminzdrav.ru/ (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">ATC/DDD Index 2017. Available from: http://www.whocc.no/ atc_ddd_index/?code.</mixed-citation><mixed-citation xml:lang="en">ATC/DDD Index 2017. Available from: http://www.whocc.no/atc_ddd_index/?code.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Colucci P, Pasternyk-Di Marco M, Potvinand D, Ducharme MP. Bioequivalence Assessment of Endogenous Drug Substances: Pharmacokinetics and Statistical Evaluation. In: Generic Drug Product Development: Bioequivalence; 2007. P. 233-56.</mixed-citation><mixed-citation xml:lang="en">Colucci P, Pasternyk-Di Marco M, Potvinand D, Ducharme MP. Bioequivalence Assessment of Endogenous Drug Substances: Pharmacokinetics and Statistical  Evaluation. In: Generic Drug Product Development: Bioequivalence; 2007. P. 233–56.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dissanayake S. Assessing the bioequivalence of analogues of endogenous substances («endogenous drugs»): considerations to optimize study design. Br Journal Clinical Pharmacology 2010; 69(3): 238-44.</mixed-citation><mixed-citation xml:lang="en">Dissanayake S. Assessing the bioequivalence of analogues of endogenous substances  («endogenous drugs»): considerations to optimize study design. Br Journal Clinical  Pharmacolîgy 2010; 69(3): 238–44.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gabrielsson J, Weiner, D. Pharmacokinetic and Pharmacodynamic data analysis: Concepts and applications. Available from: http://bit.ly/cikale4.</mixed-citation><mixed-citation xml:lang="en">Gabrielsson J, Weiner, D. Pharmacokinetic and Pharmacodynamic data analysis:  Concepts and applications. Available from: http://bit.ly/cikale4.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kressel G, Wolters M, Hahn A. Bioavailability and Solubility of Different Calcium-Salts as a Basis for Calcium Enrichment of Beverages. Food and Nutrition Sciences 2010; (1): 53-8.</mixed-citation><mixed-citation xml:lang="en">Kressel G, Wolters M, Hahn A. Bioavailability and Solubility of Different Calcium-Salts as a Basis for Calcium Enrichment of Beverages. Food and Nutrition Sciences 2010; (1): 53–8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Investigation of bioequivalence (CPMP/EWP/QWP/1401/98 Rev. 1). European Medicines Agency. Available from: https://goo.gl/de2Xjs.</mixed-citation><mixed-citation xml:lang="en">Investigation of bioequivalence (CPMP/EWP/QWP/1401/98 Rev. 1). European Medicines Agency. Available from: https://goo.gl/de2Xjs.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA. United States Food and Drug Administration. Available from: https://goo.gl/ikROcx.</mixed-citation><mixed-citation xml:lang="en">Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under  an ANDA. United States Food and Drug Administration. Available from: https://goo.gl/ikROcx.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Об утверждении Правил проведения исследований биоэквивалентности лекарственных препаратов в рамках Евразийского экономического союза. Совет Евразийской экономической комиссии. Решение от 3 ноября 2016 г. № 85. Available from: https://goo.gl/BBDlFk.</mixed-citation><mixed-citation xml:lang="en">On the adoption of Rules for carrying out bioequivalence studies of medicinal  products in the Euroasian Economic Union. Council of the Eurasian Economic  Commission. Decision of 3 November 2016 No. 85. Available from: https://goo.gl/BBDlFk (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по экспертизе лекарственных средств. Т. I. М.: Гриф и К; 2013.</mixed-citation><mixed-citation xml:lang="en">Guidance on evaluation of medicines. Vol. I. Moscow: Grif i K; 2013 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kressel G, Wolters M, Hahn A. Bioavailability and Solubility of Different Calcium-Salts as a Basis for Calcium Enrichment of Beverages. Food and Nutrition Sciences 2010; (1): 53-8.</mixed-citation><mixed-citation xml:lang="en">Kressel G, Wolters M, Hahn A. Bioavailability and Solubility of Different Calcium-Salts as a Basis for Calcium Enrichment of Beverages. Food and Nutrition Sciences 2010; (1): 53–8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Deroisy R, Zartarian M, Meurmans L, Nelissenns N, Micheletti MC, Albert A, Reginster JY. Acute hormone intake of changes in serum calcium and parathyroid circulating levels induced by the oral five currently available calcium salts in healthy male volunteers. Clinical Rheumatology 1997, 16(3): 249-53. Available from: https://goo.gl/93Cm40.</mixed-citation><mixed-citation xml:lang="en">Deroisy R, Zartarian M, Meurmans L, Nelissenns N, Micheletti MC, Albert A,  Reginster JY. Acute hormone intake of changes in serum calcium and parathyroid  circulating levels induced by the oral five currently available calcium salts in  healthy male volunteers. Clinical Rheumatology 1997, 16(3): 249–53. Available from: https://goo.gl/93Cm40.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Godfrey K. Statistics in practice: comparing the means of several groups. N Engl J Med. 1985; 313(23): 1450-6.</mixed-citation><mixed-citation xml:lang="en">Godfrey K. Statistics in practice: comparing the means of several groups. N Engl J Med. 1985; 313(23): 1450–6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dissanayake S. Assessing the bioequivalence of analogues of endogenous substances («endogenous drugs»): considerations to optimize study design. Br J Clin Pharmacol. 2010; 69(3): 238-44.</mixed-citation><mixed-citation xml:lang="en">Dissanayake S. Assessing the bioequivalence of analogues of endogenous substances («endogenous drugs»): considerations to optimize  study design. Br J Clin  Pharmacol. 2010; 69(3): 238–44.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Marzo A. Master Universitario di II Livello Ricerca e Sviluppo Pre-Clinico e Clinico del Farmaco Modulo 4. Sviluppo Clinico dei Farmaci Chieti, 14-15 novembre 2013.</mixed-citation><mixed-citation xml:lang="en">Marzo A. Master Universitario di II Livello Ricerca e Sviluppo Pre- Clinico e  Clinico del Farmaco Modulo 4. Sviluppo Clinico dei Farmaci Chieti, 14–15 novembre 2013.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Marzo A. Open questions on bioequivalence: some problems and some solutions. Pharmacol Res. 1999; 40(4): 357-68.</mixed-citation><mixed-citation xml:lang="en">Marzo A. Open questions on bioequivalence: some problems and some solutions. Pharmacol Res. 1999; 40(4): 357–68.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">El-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The Parathyroid Hormone Circadian Rhythm Is Truly Endogenous - A General Clinical Research Center Study. Journal of Clinical Endocrinology and Metabolism 1997; 82(1): 281-6.</mixed-citation><mixed-citation xml:lang="en">El-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The  Parathyroid Hormone Circadian Rhythm Is Truly Endogenous— A General Clinical  Research Center Study. Journal of Clinical Endocrinology and Metabolism 1997; 82(1): 281–6.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jacono JJ, Robertson JM. The Effects of Estrogen, Progesterone, and Ionized Calcium on Seizures during the Menstrual Cycle of Epileptic Women. Epilepsia 1987; 28(5): 571-7.</mixed-citation><mixed-citation xml:lang="en">Jacono JJ, Robertson JM. The Effects of Estrogen, Progesterone, and Ionized  Calcium on Seizures during the Menstrual Cycle of Epileptic Women. Epilepsia 1987;  28(5): 571–7.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Calcium-Regulating Hormones during the Menstrual Cycle. Journal of Clinical Endocrinology and Metabolism 1978; 47(3): 626-32.</mixed-citation><mixed-citation xml:lang="en">Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Calcium-Regulating Hormones  during the Menstrual Cycle. Journal of Clinical Endocrinology and Metabolism 1978; 47(3): 626–32.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Heller HJ, Greer LG, Haynes SD, Poindexter JR, Pak CYC. Pharmacokinetic and Pharmacodynamic Comparison of Two Calcium Supplements in Postmenopausal Women. Journal of Clinical Pharmacology 2000; 40(11): 1237-44.</mixed-citation><mixed-citation xml:lang="en">Heller HJ, Greer LG, Haynes SD, Poindexter JR, Pak CYC. Pharmacokinetic and  Pharmacodynamic Comparison of Two Calcium Supplements in Postmenopausal Women.  Journal of Clinical Pharmacology 2000; 40(11): 1237–44.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ekman M, Reizenstein R, Teigen SW, Ronneberg R. Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet and chloride solution. Bone 1991; 12(2): 93-7.</mixed-citation><mixed-citation xml:lang="en">Ekman M, Reizenstein R, Teigen SW, Ronneberg R. Comparative absorption of  calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet and chloride solution. Bone 1991; 12(2): 93–7.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Need AG, Horowitz M, Philcox JC, Nordin BEC. Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium. Miner Electrolyte Metab. 1987; 13(2): 112-6.</mixed-citation><mixed-citation xml:lang="en">Need AG, Horowitz M, Philcox JC, Nordin BEC. Biochemical effects of a calcium  supplement in osteoporotic postmenopausal women with normal absorption and  malabsorption of calcium. Miner Electrolyte Metab. 1987; 13(2): 112–6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Nicar MJ, Pak CY. Calcium bioavailability from calcium carbonate and calcium citrate. Journal of Clinical Endocrinology and Metabolism 1985; 61(2): 391-3.</mixed-citation><mixed-citation xml:lang="en">Nicar MJ, Pak CY. Calcium bioavailability fromcalcium carbonate and calcium  citrate. Journal of Clinical Endocrinology and Metabolism 1985; 61(2): 391–3.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Reginster JY, Denis D, Albert A, Gaspar S, Heynen G, Deroisy R, Franchimont R. Influence of the nature of calcium salts on serum calcium, phosphorus, calcitonin, growth hormone, and somatomedin C. Res Exp Med. 1988; 188(2): 131-7.</mixed-citation><mixed-citation xml:lang="en">Reginster JY, Denis D, Albert A, Gaspar S, Heynen G, Deroisy R, Franchimont R.  Influence of the nature of calcium salts on serum calcium, phosphorus, calcitonin,  growth hormone, and somatomedin C. Res Exp Med. 1988; 188(2): 131–7.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Reginster JY, Denis D, Bartsch V, Deroisy R, Zegels B, Franchimont P. Acute biochemical variation induced by four different calcium salts in healthy male volunteers. Osteoporos Int. 1993; 3(5): 271-5.</mixed-citation><mixed-citation xml:lang="en">Reginster JY, Denis D, Bartsch V, Deroisy R, Zegels B, Franchimont P. Acute  biochemical variation induced by four different calcium salts in healthy male volunteers. Osteoporos Int. 1993; 3(5): 271–5.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Reid IR, Schooler BA, Hannan SE, Ibbertson HK. The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med. 1986; 16(2): 193-7.</mixed-citation><mixed-citation xml:lang="en">Reid IR, Schooler BA, Hannan SE, Ibbertson HK. The acute biochemical effects of  four proprietary calcium preparations. Aust N Z J Med. 1986; 16(2): 193–7.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Sheikh MS, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med. 1987; 317(9): 532-6.</mixed-citation><mixed-citation xml:lang="en">Sheikh MS, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium frommilk and calcium salts.N Engl J Med. 1987; 317(9): 532–6.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Woo J, Swaminathan R, Lau E, Mac Donald D, Pang CP, Nordin BEC. Biochemical effects of a single dose of oral calcium on bone metabolism in elderly Chinese women. Calcif Tissue Int. 1991; 48: 157-60.</mixed-citation><mixed-citation xml:lang="en">Woo J, Swaminathan R, Lau E, Mac Donald D, Pang CP, Nordin BEC. Biochemical  effects of a single dose of oral calcium on bone metabolism in elderly Chinese women. Calcif Tissue Int. 1991; 48: 157–60.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
